Courses   Wikipedia   PubMed   Dictionary  
Username:
Password:
 
Create a CE-TODAY Account
Free Subscription
 You are here:   Nurse Practitioners Home  >>   Program CD0094  >>   Course AB0436
ACCREDITATION
SUPPORTER INFORMATION
CERTIFICATE FEES
PRINTABLE RESOURCES
You will need:

Depression: When and How to Treat a Debilitating Disease
Feedback
FAQ

 

Valerie A. Hart, EdD, APRN, CS

This feature article presents a systematic review of the pathophysiology of various forms of depression. Recent data on pharmaceutical and nonpharmaceutical interventions for specific depressive illnesses and criteria for referral will be reviewed.

Supported by an educational grant from:

OVERVIEW
An estimated 4.6% to 8.6% of patients seen by primary care professionals suffer from depression and only about one-third to one-half of those depression cases are detected during a consultation. Changes in the way healthcare is delivered make it more important than ever for primary care professionals to assume responsibility for the diagnosis and treatment of this common disorder. This article provides an overview of the pharmacologic options for treating the many forms of this debilitating disease. Criteria for deciding when to refer a patient to a mental health professional are also discussed.
[Top]
OBJECTIVES
Upon completion of this course, you should be able to:
  • Describe the pathophysiology of the various forms of depression

  • Describe the pharmaceutical and nonpharmaceutical options for treating various types of depression

  • Identify criteria for referring patients to a mental health professional

[Top]
 
TARGET AUDIENCE
These CE activities are designed for nurse practitioners as well as other healthcare providers who are involved in the care of patients with depression.
[Top]
LEARNER PARTICIPATION

[Top]
CONFLICT OF INTEREST RESOLUTION

As an ACCME accredited provider, MEBN must ensure balance, independence, objectivity and scientific rigor in all of its educational activities. All faculty participating in these activities are expected to disclose any or no relevant financial interest or other relationship with (1) the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in any educational presentation, and/or (2) with any commercial supporters of an activity. Disclosure of any or no relationship(s) will be listed prior to any educational activity.

All apparent conflicts of interest have been identified and resolved through MEBN’s independent, peer-review process. Our intent is to assist learners in assessing the potential for bias in information that is presented during the educational activity. The faculty are also aware of their responsibility to inform the audience if discussion of any non-FDA-approved uses of pharmaceuticals, medical equipment, prostheses, etc. will be included in their presentation.

Unless otherwise indicated, MEBN staff and writers have no financial relationships with a commercial party to disclose.

[Top]
 
ACCREDITATION STATEMENT
Continuing Medical Education for Nurse Practitioners
These activities have been granted 1 contact hour(s) of continuing education (which includes .6 hours of pharmacology) by the American Academy of Nurse Practitioners, Program ID 0707301
 
Accreditation Period
These activities were initially published on August 1, 2005, were reviewed on July 31, 2007, and are eligible for credit through July 31, 2009.
[Top]
 
DISCLAIMER

Disclaimer
This continuing education program may contain discussion of published and/or investigational uses of agents or products that are not approved by the Food and Drug Administration (FDA). The authors, sponsors or publishers do not recommend the use of any agent or product outside of the official labeled indications. Please refer to the official prescribing information for each agent or product for discussion of approved indications, contraindications, and written warnings.

Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this course should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

The authors, contributors, and editorial staff have made every effort to contact holders of copyright to obtain permission to reproduce copyright material. However, if any permissions have been inadvertently overlooked, MEBN will be pleased to make the necessary and reasonable arrangements.

[Top]
 
SUPPORTER

Supported by an educational grant from
 

Jointly sponsored by
 

www.gsk.com www.aanp.org
[Top]
 
CERTIFICATE FEES

CE-TODAY offers FREE continuing education (CE) credits to recipients of the CD-ROM or the CE-TODAY journal. Enter the CE Code listed on the CD-ROM or in the journal when prompted. This free offer expires on December 31, 2006. All others will be assessed a $10.00 processing fee.

[Top]